Effect of lacidipine on the carotid intimal hyperplasia induced by cuff injury
- PMID: 7609512
- DOI: 10.1097/00005344-199423005-00015
Effect of lacidipine on the carotid intimal hyperplasia induced by cuff injury
Abstract
The in vivo antiatherogenic activity of the calcium antagonist lacidipine was investigated in arterial hyperplasia induced by perivascular manipulation of hypercholesterolemic carotid rabbits. This was accomplished by positioning a hollow silastic collar around one carotid, which within a few days induces an atherosclerotic lesion (proliferative lesion) showing biochemical and morphologic changes similar to those of early human atherosclerosis: the contralateral carotid, with no collar, served as control in the same animal. The effect of lacidipine was also investigated in aortic atherosclerotic lesions (fatty lesions) induced by hypercholesterolemia mixed with either cholesterol (1%) and lacidipine (3 mg/kg/day) or cholesterol (1%) alone for 8 weeks. Hypercholesterolemic New Zealand White rabbits were fed daily a standard diet. Intimal hyperplasia was mechanically induced in one carotid artery of each rabbit 6 weeks after dietary and drug treatment started. Neointimal formation was followed by measuring by light microscopy the cross-sectional thickness of intimal (I) and medial (M) tissue of fixed arteries. In positive control animals receiving dietary cholesterol only (n = 10), by 14 d after collar positioning the process of intimal hyperplasia was significantly pronounced. The control arteries showed an I:M tissue ratio of 0.03 +/- 0.02, whereas in the carotid with collar the ratio was 0.56 +/- 0.11. In the animals receiving lacidipine, neointimal formation was significantly lower [I:M tissue ratio 0.32 +/- 0.1 (n = 10), about 60% of positive controls]. Measurement of the percent area of the aortic intima covered by plaques did not show significant differences between control and lacidipine-treated animals. These results suggest a direct antiatherosclerotic effect of lacidipine on proliferative lesions.
Similar articles
-
Effect of lacidipine on fatty and proliferative lesions induced in hypercholesterolaemic rabbits.Br J Pharmacol. 1996 May;118(2):215-9. doi: 10.1111/j.1476-5381.1996.tb15389.x. Br J Pharmacol. 1996. PMID: 8735617 Free PMC article.
-
Direct antiatherogenic activity of isradipine and lacidipine on neointimal lesions induced by perivascular manipulation in rabbits.Pharmacol Res. 1997 May;35(5):417-22. doi: 10.1006/phrs.1997.0153. Pharmacol Res. 1997. PMID: 9299204
-
Effect of lercanidipine and its (R)-enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits.Br J Pharmacol. 1998 Dec;125(7):1471-6. doi: 10.1038/sj.bjp.0702221. Br J Pharmacol. 1998. PMID: 9884075 Free PMC article.
-
The antiatherosclerotic effects of calcium antagonists.J Cardiovasc Pharmacol. 1995;25 Suppl 3:S6-10. J Cardiovasc Pharmacol. 1995. PMID: 8852538 Review.
-
Endothelial dysfunction, hypertension and atherosclerosis. A review of the effects of lacidipine.Drugs R D. 2002;3(5):311-23. doi: 10.2165/00126839-200203050-00005. Drugs R D. 2002. PMID: 12455152 Review.
Cited by
-
Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.Drugs. 1994 Aug;48(2):274-96. doi: 10.2165/00003495-199448020-00010. Drugs. 1994. PMID: 7527328 Review.
-
Nutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk Reduction.Mar Drugs. 2016 Jun 8;14(6):113. doi: 10.3390/md14060113. Mar Drugs. 2016. PMID: 27338419 Free PMC article. Review.
-
Biotechnology Approaches for the Treatment of Dyslipidemia.Cardiovasc Drugs Ther. 2021 Feb;35(1):167-183. doi: 10.1007/s10557-020-07017-6. Cardiovasc Drugs Ther. 2021. PMID: 32519066
-
Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation.Nutrients. 2018 Sep 6;10(9):1249. doi: 10.3390/nu10091249. Nutrients. 2018. PMID: 30200592 Free PMC article. Review.
-
Effects of Marine-Derived Components on Cardiovascular Disease Risk Factors and Gut Microbiota Diversity.Mar Drugs. 2024 Nov 20;22(11):523. doi: 10.3390/md22110523. Mar Drugs. 2024. PMID: 39590803 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources